Category: Research & Clinical Trials

A new report shows shipbreaking workers exposed to asbestos are at risk of developing esophageal, liver, tracheal, bile duct and lung cancers.

Dr. Robert Cameron and other mesothelioma specialists are set to discuss latest treatment breakthroughs with health care professionals and the public.

A new collection of medical-based apps, called ResearchKit, may revolutionize how researchers track clinical trial participants.

Early results from a clinical trial that mirrors a multicenter study shows immunotherapy drug tremelimumab is extending patients’ lives.

New study shows sheet metal workers in the U.S. who are exposed to asbestos indirectly are still at risk of developing mesothelioma and other diseases.

Researchers at Case Western Reserve University find that Adcetris lymphoma drug may fight and kill some mesothelioma cell lines containing CD30 protein.

Mesothelioma researchers may be able to tap into $50 million in cancer research funds from the Department of Defense later this year.

A clinical trial in the U.K. is testing the value of post-surgery radiotherapy in reducing new tumor growth in areas where surgeons make their incisions.

Researchers will test how effectively defectanib (VS-6063) can kill mesothelioma stem cells in expansive, ongoing clinical trial.

Researchers conducting multicenter clinical trials using nintedanib, known by its brand name Ofev, say the new drug may relieve mesothelioma symptoms.

A study of taconite workers in Minnesota’s Iron Range showed they were at higher risk of developing mesothelioma and heart disease.

Dr. Michele Carbone and other researchers find the BAP1 gene, which increases risk of mesothelioma, also can boost survival time in some patients.

Help could be on the way for future mesothelioma patients who need it the most.
Researchers in Spain are the first to successfully identify a specific protein found only in mesothelioma patients with the shortest survival times.
The findings should pro…

An immunotherapy trial that successfully reduced a bile duct cancer patient’s tumors could result in breakthrough mesothelioma treatment.

Researchers at Case Western Reserve University say curcumin, a component of the spice turmeric, may slow tumor growth in mesothelioma patients.